Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993)
Chapter: B5. Use of Antiprogestins Before 63 Days of Amenorrhea
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
B4. Potential Contraceptive Effects of Antigestogens
Next Chapter: B6. Uses of Antiprogestins After 63 Days of Amenorrhea
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.